1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Gilead Sciences Funding for Innovative, High-Impact Projects is sponsored by Gilead Sciences. Gilead Sciences welcomes funding requests for innovative, high-impact projects that relate to at least one of their core therapeutic areas: HIV, Liver Disease (Hepatitis C, B, D, Primary biliary cholangitis), Oncology (Hematology, Solid tumors), and Chronic Inflammatory Diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Gilead Sciences: How to Apply for Grant Funding We support community-informed, data-driven programs that strengthen healthcare infrastructures and provide education and financial support to the most vulnerable communities around the world. Our corporate giving programs focus support where the need is greatest and we prioritize applications that demonstrate a strong capability to deliver the specific outcomes the grant would support.
Grant applications are accepted throughout the year. We welcome funding requests for innovative, high-impact projects that relate to at least one of our core therapeutic areas: Primary biliary cholangitis Chronic Inflammatory Diseases Patient Community Support We strive to advance health equity, diversity in clinical trials and access to medicines to reduce disparities. We also support the local communities in which we operate.
Examples of Patient Community Support projects: Events or resources to educate patients about prevention and care options, such as: Testing and screening initiatives Types of organizations we have funded: Patient advocacy and support groups Nonprofit service organizations Professional associations Academic medical centers and universities Many individuals face barriers to accessing healthcare due to age, disability, ethnicity or race, location, gender, gender identity or socioeconomic status.
To help ensure all people have the opportunity to get the best possible care – regardless of background – Gilead sponsors select events or conferences that raise awareness and support organizations working in our therapeutic areas of focus. Events Gilead has sponsored include: Note: If you are seeking funding for a local event exhibit or display that will appear at a local program, please contact your local Gilead field sales employee.
We work with patient advocates, nonprofits, and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement. Latin America & the Caribbean We support high-impact continuing medical education programs that expand the knowledge and skills of healthcare providers. There are two funding pathways: Independent Medical Education (IMED) and Medical-Scientific.
Research Funding Programs Gilead funds externally-sponsored research, including community-based participatory research, and has a Research Scholars Program across our therapeutic areas of virology, oncology and inflammation.
According to the current listing, eligibility includes: Patient advocacy and support groups, hospitals and clinics, nonprofit service organizations, professional associations, academic medical centers and universities. Confirm the full requirements in the official notice before applying.
Gilead Sciences Funding for Innovative, High-Impact Projects is funded by Gilead Sciences. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleSchmidt Sciences opened a 'Scaling AI Safety for a Multi-Agent World' program with awards up to $1 million and an August 8, 2026 deadline. Against a backdrop of federal research slowdowns, here is why private science philanthropy matters more than ever, how these funders differ from federal agencies, and how researchers should approach them.
Read articleNSF's Arctic Research Opportunities solicitation funds roughly 75 awards a year — up to $50 million — across six program areas from natural sciences to social sciences to the Arctic Observing Network. The July 15, 2026 target date is not a hard deadline, and understanding that distinction is the first strategic decision an Arctic researcher makes. Here is how the six doors differ and how to choose the right one.
Read article